Geron Corporation (GERN)

NASDAQ: GERN · USD

$0.97

-0.18 (-15.8%)· Recorded snapshot

Market cap	622.2M
Revenue (ttm)	204.6M
Net income (ttm)	-67.6M
EPS (ttm)	-$0.10
Shares out	642.5M
P/E (forward)	85.6x
Volume	80,547,921
Beta	0.61

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 204.6M
Net income (ttm): -67.6M
EPS (ttm): -$0.10
P/E (forward): 85.6x
Market cap: 622.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Manter

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E85.6

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-28.3

P25 n/aP50 n/aP75 n/a

ROIC-6.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All GERN indicators

Market & fundamental data

Available fields

217

Groups with data

Currency

USD

Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000886744
Company name	Geron Corporation
Country	United States
Country code	US
CUSIP number	374163103
Earnings date	2026-11-04
Earnings time	bmo
Employees	258
Employees change	29
Employees growth	12.66%
Enterprise value	$419.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1990
In index	RUSSELL2000
Industry	Biotechnology
IPO date	1996-06-30
Is primary listing	Yes
Is SPAC	No
ISIN number	US3741631036
Last 10-K release date	2026-03-02
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$622.2M
Market cap category	Small-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$0.97
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	GERN
U.S. state	California
Website	https://www.geron.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-10.44%
EV/Sales	1.84x
FCF / EV yield	-30.41%
FCF yield	-19.78%
Forward EV/Sales	1.32x
Forward P/E	85.6x
Forward P/S	2.04x
P/B ratio	3.38x
P/S ratio	2.84x
Price / tangible book value	2.65x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-17.25%
EBITDA margin	-17.01%
Gross margin	58.5%
Operating margin	-17.25%
Pretax margin	-33.05%
Profit margin	-33.05%
Profit per employee	$-262,062
Revenue per employee	$792,864
ROA	-4.11%
ROA (5Y)	-27.85%
ROCE	-7.86%
ROE	-28.28%
ROE (5Y)	-83.54%
ROIC	-6.11%
SBC / revenue	10.96%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	3
Gross profit growth	48.82%
Gross profit growth (Q)	0.38%
Net income growth years	2
Revenue growth	24.39%
Revenue growth (Q)	17.22%
Revenue growth (QoQ)	10.89%
Revenue growth 10Y	18.8%
Revenue growth 3Y	668.9%
Revenue growth 5Y	247.79%
Revenue growth quarters	10
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-386,000
Depreciation and amortization	$485,000
EBIT	$-35.3M
EBITDA	$-34.8M
EPS	$-0.10
FCF per share	$-0.18
Financing cash flow	$4.7M
Free cash flow	$-114.8M
Free cash flow minus SBC	$-137.2M
Gross profit	$119.7M
Investing cash flow	$94.6M
Net cash flow	$-15.1M
Net income	$-67.6M
Operating cash flow minus SBC	$-136.8M
Operating income	$-35.3M
Revenue	$204.6M
Stock-based compensation	$22.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-2.17
Book value per share	$0.34
Debt / equity	0.56
Interest coverage	-1.17
Long-term assets	$32.7M
Long-term liabilities	$230.1M
Net cash (debt)	$202.8M
Net cash / market cap	34.96%
Net cash growth	-34.33%
Net debt / equity	-0.93
Piotroski F-Score	2
Property, plant and equipment	$2.9M
Shareholders' equity	$218.6M
Tangible book value	$218.6M
Tangible book value per share	$0.34
Total assets	$519M
Total cash	$300.8M
Total debt	$122.1M
Total liabilities	$300.4M
WACC	9.69%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.38
Current assets	$486.3M
Current liabilities	$70.3M
Current ratio	6.92
Inventory turnover	0.88
Net working capital	$116.2M
Quick ratio	5.04
Working capital	$416M
Working capital turnover	0.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.6%
Dividend yield	0%
Shareholder yield	-0.6%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-51.82%
10Y return CAGR	-7.04%
10Y total return	-51.82%
150-day SMA	$1.39
15Y price change	-62.47%
15Y return CAGR	-5.78%
15Y total return	-59.08%
1D price change	-15.79%
1M price change	-23.14%
1M total return	-23.14%
1W price change	-16.52%
1W total return	-16.52%
1Y price change	-24.34%
1Y return CAGR	-24.36%
1Y total return	-24.34%
20-day SMA	$1.18
200-day SMA	$1.43
20Y price change	-87.66%
20Y return CAGR	-9.54%
20Y total return	-86.55%
3M price change	-34.57%
3M total return	-34.57%
3Y price change	-45.9%
3Y return CAGR	-18.51%
3Y total return	-45.9%
50-day SMA	$1.32
50-day SMA vs 200-day SMA	50under200
52-week high	$2.01
52-week high date	2026-02-19
52-week low	$0.84
52-week low date	2026-10-28
5Y price change	-33.21%
5Y return CAGR	-7.76%
5Y total return	-33.21%
6M price change	-36.71%
6M total return	-36.71%
All-time high	$75.88
All-time high date	2000-03-03
All-time low	$0.75
All-time low date	2020-03-16
Average true range (ATR)	$0.08
Average volume	11.1M
Beta (1Y)	1.66
Beta (2Y)	1.47
Beta (5Y)	0.61
Change from 52-week high	-51.82%
Change from 52-week low	15.29%
Change from all-time high	-98.72%
Change from all-time low	29.12%
Change from open	-5.98%
Day's gap	-10.43%
Dollar volume	$78M
High price	$1.04
Low price	$0.84
Monthly RSI	36.92
Open price	$1.03
Position in 52-week range	63.8%
Premarket change	-8.7%
Premarket close	$1.15
Premarket price	$1.05
Premarket volume	3.3M
Previous close	$1.15
Price vs 150-day SMA	-30.33%
Price vs 20-day SMA	-17.93%
Price vs 200-day SMA	-32.23%
Price vs 50-day SMA	-26.47%
Relative volume	7.28
RSI	25.71
Sharpe ratio	-0.17
Sharpe ratio (3Y)	0.07
Sharpe ratio (5Y)	0.22
Sortino ratio	-0.16
Sortino ratio (3Y)	0.22
Sortino ratio (5Y)	0.48
Volume	80.5M
Weekly RSI	33.47
YTD price change	-26.64%
YTD total return	-26.64%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	556.3M
Float percentage	86.59%
Shares change (QoQ)	0.2%
Shares change (YoY)	0.6%
Shares held by insiders	0.08%
Shares held by institutions	61.51%
Shares outstanding	642.5M
Short % of float	13.28%
Short % of shares	11.5%
Short ratio	6.7 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	182

Deeper analysis on GERN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this GERN report

Is a complete GERN research report available?

No complete published report is available for Geron Corporation (GERN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Geron Corporation (GERN)

Price

Financial snapshot

Fair-value bridge

Latest news · GERN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GERN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on GERN

Frequently asked questions